Cannabis Law Report

JUNE 21, 2021

We would love to have you tune in to the discussion as our expert panelists discuss the following topics: Navigating regulatory compliance; Where to start and how. FDA, USDA, DEA basics. Useful resources. Appropriate vs. inappropriate health claims. Labeling requirements differ state to state- how to track.

Hemp 71

Hemp DEA Compliance Compliance 71

SpeedWeed

JUNE 8, 2021

Drug Enforcement Administration (DEA) ruled that Delta-8 THC, a cannabinoid that occurs naturally and can also be processed from CBD, is a controlled substance not protected by the 2018 Farm Bill, which legalized hemp agriculture and products derived from the crop. Last year, the U.S. View original article.

Topical 40

Topical THC Agriculture Cannabinoids 40

CannaMD

NOVEMBER 20, 2020

So, whether you’re looking to avoid a confrontation with that one relative who always posts the most infuriating things or simply spice up your turkey-time conversations, CannaMD has curated five topics sure to change the subject and get everyone talking! The Mississippi Monopoly.

Therapy 104

Therapy Treatment DEA CBD 104

Veriheal

AUGUST 24, 2022

So much, in fact, that it actually gained the attention of the DEA , which recently called for an increase in psychedelic production for research purposes. In recent years, much progress has been made surrounding the research of the therapeutic properties these compounds may possess.

Legalization 111

Legalization Decriminalization Medicine Research and Development 111

Cannabis Law Report

FEBRUARY 11, 2020

DEA and Hemp-Derived CBD. The DEA, as most of you may know, finds and eliminates any illicit substances that may be present in a community – this implies hard drugs and such. . After the Farm Bill was passed, the DEA stated that CBD itself is not illegal, because it is dependent on the cannabis or hemp plant. The Bottom Line.

Law 45

Law CBD DEA Hemp 45

Cannabis Law Report

JULY 1, 2021

In the following interview, which has been edited and condensed, Senior Fellow and POPLAR Project Lead Mason Marks explains how POPLAR will fill this gap, and previews some of the initiative’s topics of inquiry. Chloe Reichel: Can you describe the primary goals of POPLAR?

Law 81

Law Research and Development Therapy DEA 81

Medicinal Genomics

FEBRUARY 8, 2023

Check out our CannMed Archives to watch videos of presentations from previous CannMed events to see for yourself, and check out our Speakers Page to learn more about the CannMed 23 presenters and their topics! Check out the CannMed 23 Speaker page to learn more about the presenters and the topics they plan to cover at CannMed 23!

Wellness and Beauty 52

Wellness and Beauty Topical Events Safety 52

Cannabis Law Report

JANUARY 19, 2022

The US Food and Drug Administration (FDA) and potentially the Drug Enforcement Agency (DEA), could bring enforcement action against producers of some of these intoxicating products if they so choose. Key Topics Covered: Executive summary. There is no indication that any enforcement action is imminent. Legal framework.

Hemp 40

Hemp DEA Cannabinoids Topical 40

The Blunt Truth

DECEMBER 26, 2019

January proved that there’s always a cannabis angle, no matter what the topic of conversation. In October, Senator Mitch McConnell directed the DEA to figure out how to distinguish hemp from marijuana. In tribute to Dave Barry and his always hilarious Year in Review , we’ll organize these stories by month.

Banking 71

Banking Hemp Agriculture Seed-To-Sale 71

Cannabis Law Report

AUGUST 12, 2022

Drug policy topics have become a consistent feature of the Austin-based event in recent years as more states have legalized cannabis and moved to reform laws around psychedelics like psilocybin locally and at the state level. Obtaining DEA License to Grow Psilocybin Mushrooms. Here are some psychedelics panel options: .

Research and Development 52

Research and Development Topical Events Policy 52

LifeCannMD

APRIL 19, 2021

Applied topically, Delta-8 reduced pain and inflammation through its effects on the CB1 receptors. In the Fall of 2020, the DEA issued an “Interim Final Rule” which states that “synthetically derived tetrahydrocannabinol” are still Schedule I controlled substances.

THC 52

THC DEA Concentrates Cannabinoids 52

United Patients Group

APRIL 3, 2023

Epidiolex, an FDA-approved medication containing CBD (cannabidiol), has been listed as Schedule 5 by the DEA since June 25th, 2019. Epidiolex, an FDA-approved medication containing CBD, has been listed as Schedule 5 classification by the DEA since June 25th, 2019. Cannabis is a schedule 1 substance.

DEA 52

DEA Patients Conditions Cannabis 52

The Blunt Truth

OCTOBER 24, 2019

Cannabis research was also a big topic. Circuit Court refuse to involve itself in the company’s fight with the DEA over cannabis research licenses. New Mexico’ s legalization task force has released its final report. It would allow for expungement of low-level marijuana convictions, but would not permit home growing.

Hemp 58

Hemp DEA CBD Topical 58

Marijuana Seeds NL

APRIL 29, 2021

Considering retail sales of delta 8 flower and goods was $10 million in 2020 - it’s a topic states and producers will need to sort out. This may be one reason why the DEA took some federal action in August of 2020. Instead of bans, some states like Florida are deriving their own legal framework for the future of delta-8 THC use.

THC 52

THC DEA Cannabinoids Extraction 52

Cannabis Law Report

OCTOBER 15, 2019

We have noted previously that the federal Drug Enforcement Agency (DEA) recently announced that drugs that include CBD (cannabidiol) with less than 0.1% That laboratory informed plaintiff that it could not run the tests on the Dixie X as the substance was illegal and contained THC levels well over the federal limit as per DEA regulations.

THC 40

THC CBD DEA Policy 40

Medicinal Genomics

JULY 13, 2023

one of just seven federally DEA- licensed cannabinoid research labs, had some encouraging news about how cannabinoids and cannaflavins can lengthen life spans while improving health spans. Watch Dr. Russo’s Presentation Hunter Land, Ph.D, the VP of Research & Development at Biopharmaceutical Research Company, Inc.,

Research and Development 52

Research and Development Cannabinoids Medicine DEA 52

Kind Meds (Cannabis Education Blog)

SEPTEMBER 4, 2019

But what’s behind the cannabis confections, concentrates, topicals, and sweet flowers that we’ve come to enjoy? Until the FDA and DEA change the way they classify marijuana, consumers, big cannabis business and its shareholders and stockholders are somewhat at their mercy. Cannabis consumers aren’t one in the same. It depends.

Dispensary 69

Dispensary Research and Development Pets Patients 69

Cannabis Law Report

JANUARY 11, 2019

Accordingly, the Drug Enforcement Administration (DEA) no longer has any claim to interfere with the interstate commerce of hemp products, so as long as the THC level is at or below 0.3%. While the DEA is now officially out of the hemp regulation business, the U.S. The FDA’s position on CBD is unsettled and unsupported by law.

Hemp 49

Hemp CBD Law Seed-To-Sale 49

SMPL

AUGUST 14, 2019

ABA noted that the Drug Enforcement Administration (DEA) announced in 2016 that it is accepting applications for additional cannabis manufacturers, which could bolster research, for example. One area that could be quickly improved is in the sourcing of research-grade marijuana.

Policy 40

Policy Research and Development Marijuana DEA 40

Cannabis Law Report

JUNE 25, 2021

Drug Enforcement Agency (DEA)’s narcotic drug schedule as defined by the Controlled Substances Act (CSA). While the FDA doesn’t have age restrictions in place for uses of CBD like topicals and oils, it does suggest that that any smokable flower or vaping oils be sold only to individuals aged 18 and older.

Banking 51

Banking CBD Hemp Seed-To-Sale 51

The Fresh Toast

APRIL 17, 2023

5 Facts About Glaucoma And Medical Marijuana Medical marijuana glaucoma treatment can help reduced eye pressure and relieve pain. Here's what you need to know about using cannabis for eye health. The post 5 Facts About Glaucoma And Medical Marijuana appeared first on The Fresh Toast.

Marijuana 98

Marijuana Treatment DEA Topical 98

SpeedWeed

APRIL 1, 2021

Fried remembers the debate, featuring a then- High Times editor and a DEA agent, marking the first substantive cannabis conversation during her time at school. . While some are coming around on the topic, that hasn’t been the case for previous Governor Rick Scott or the current leader of the state, Ron DeSantis.

Agriculture 52

Agriculture Policy THC Advocacy 52

Cannabis Law Report

JUNE 1, 2021

33%. – Beverages, edibles, topicals. and vapes. 14%. – Beverages, edibles, topicals. and vapes. Drug Enforcement Administration (the “DEA”), the U.S. Beverages, edibles, topicals and vapes. Beverages, edibles, topicals and vapes. – – Oils and softgels8.

Data 95

Data Vaping Supply Chain Business 95

Cannabis Law Report

FEBRUARY 17, 2020

It has been less than eight years since the DEA, the Criminal Investigation Division of IRS, and the Office of the U.S. We have previously written on this topic. The announcement would have explained the pending criminal investigation relates to public corruption, tax evasion and money laundering. See Reboot in 2020! ,

Collective 59

Collective Business Cultivation Compliance 59

Kind Meds (Cannabis Education Blog)

SEPTEMBER 4, 2019

But what’s behind the cannabis confections, concentrates, topicals, and sweet flowers that we’ve come to enjoy? Until the FDA and DEA change the way they classify marijuana, consumers, big cannabis business and its shareholders and stockholders are somewhat at their mercy. It depends. Why the Local Grow Is a Trusted Resource.

Marijuana 40

Marijuana Dispensary Research and Development Pets 40

Otherside Farms

AUGUST 4, 2020

Since marijuana regulation is such a new topic, store owners can expect to jump through many hoops to secure proper licensing like making sure their store is a certain distance away from schools. Banks have not been fond of supporting dispensaries in the fear that funds may get frozen by DEA or the feds.

Business 52

Business Banking Dispensary Research and Development 52

Cannabis Law Report

AUGUST 6, 2021

Beverages, edibles, topicals 7. and vapes. Beverages, edibles, topicals. and vapes. Drug Enforcement Administration (the “DEA”), the U.S. Other revenue adjustments 8. $(3.0). Excise taxes. Medical cannabis and other. – Oils and softgels. Excise taxes. $(1.4). state and federal law to U.S.

Vaping 105

Vaping Research and Development Data Business 105

The Fresh Toast

APRIL 2, 2019

Glaucoma And Medical Marijuana: 5 Informative Facts Medical marijuana glaucoma treatment can help reduced eye pressure and relieve pain. Here's what you need to know about using cannabis for eye health. The post Glaucoma And Medical Marijuana: 5 Informative Facts appeared first on The Fresh Toast.

Marijuana 79

Marijuana Treatment DEA Topical 79

The Cannigma

JULY 3, 2023

Sometimes insufflated Inhalation, oral, topical, sublingual and transdermal Other names E, X, Ecstasy, Molly, XTC, The Love Drug Weed, marijuana, pot, ganja, dope, grass… the list goes on.

Research and Development 46

Research and Development Environment THC Microdosing 46

Cannabis Law Report

JULY 14, 2021

Cannabis banking has been a tricky topic to tackle in recent years. Drug Enforcement Agency (DEA) to the Alcohol and Tobacco Tax and Trade Bureau (TTB), the Bureau of Alcohol Tobacco Firearms and Explosives (ATF), as well as the Food and Drug Administration (FDA) to protect public health. Ganjapreneur. Marijuana Times.

Legislation 71

Legislation Banking History Access 71

Kind Meds (Cannabis Education Blog)

JULY 6, 2021

At this point, it has actually become something of a hot topic — still, not everyone has the clearest understanding of what delta-8 even is, or where it can be purchased. It’s been proposed by the federal Drug Enforcement Administration (DEA), however, that delta-8 be indirectly classified as a Schedule 1 controlled substance.

THC 52

THC CBD Edibles Hemp 52

Cannabis Law Report

JULY 30, 2019

Cannabis is not a “gateway” drug, according to the ASA and the DEA’s own statements cited in the August 2016 U.S. Edibles and topicals emerged as the two categories users indicated that were consuming more of post-legalization. . Download : Cannabis Misinformation: What Does the DEA say about Marijuana?

Marijuana 45

Marijuana Patients Research and Development Programs 45

Cannabis Law Report

SEPTEMBER 23, 2019

Marijuana and CBD are most commonly used via inhalation, ingestion, and topical absorption. 17 Topical cannabis is applied to, and absorbed through, the skin in a cream or salve form. 19 Topical administration of cannabis or cannabinoids has variable onset and duration. Cannabis sativa with less than 0.3%

Cannabinoids 40

Cannabinoids Marijuana Research and Development Access 40

Canna Law Blog

JULY 16, 2024

In case you haven’t heard, the Drug Enforcement Administration (DEA) wants to hear from you on marijuana rescheduling. Specifically, DEA invites your comments on its notice of proposed rulemaking (NPRM) to move both marijuana and marijuana extract from schedule I to schedule III of the federal Controlled Substances Act (CSA).

DEA 111

DEA Marijuana Topical Policy 111

The Fresh Toast

APRIL 2, 2019

Glaucoma And Medical Marijuana: 5 Informative Facts Medical marijuana glaucoma treatment can help reduced eye pressure and relieve pain. Here's what you need to know about using cannabis for eye health. The post Glaucoma And Medical Marijuana: 5 Informative Facts appeared first on The Fresh Toast.

Marijuana 44

Marijuana Treatment DEA Topical 44

Canna Law Blog

OCTOBER 3, 2020

The USDA is particularly interested in comments on certain topics and, in my prior post, I discussed one of those topics, Liquid Chromatography Factor, 0.877, and its importance to the Hemp-CBD industry. Today let’s discuss another topic, Sampling Methodology – Flower v. The 2018 Farm Bill Does Not Support the DEA Interim Rule.

Hemp 98

Hemp DEA CBD Topical 98

The Cannigma

JUNE 14, 2021

All that is about to change, thanks to a change at the DEA , which cultivators and industry experts say will be monumental for cannabis research, medical marijuana patients, and potentially the broader legal status of the plant itself. “We BRC) told The Cannigma this week. Junk’ cannabis ‘ill-suited for clinical trials’. Shutterstock).

DEA 133

DEA Research and Development Clinical Trials Pharmaceutical 133